Optimally discriminative subnetwork markers predict response to chemotherapy
暂无分享,去创建一个
Martin Ester | Süleyman Cenk Sahinalp | Anna Lapuk | Kendric Wang | Colin Collins | Phuong Dao | A. Lapuk | S. C. Sahinalp | C. Collins | Phuong Dao | Kendric Wang | M. Ester
[1] R. Bernards,et al. Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.
[2] Christian von Mering,et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..
[3] Akhilesh Pandey,et al. Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. , 2009, Methods in molecular biology.
[4] P. Lollini,et al. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] Alan Ashworth,et al. Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance , 2006, Breast Cancer Research and Treatment.
[6] J. Bartlett,et al. Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge , 2010, Oncogene.
[7] Igor Jurisica,et al. Protein complex prediction via cost-based clustering , 2004, Bioinform..
[8] Edward R. Dougherty,et al. Identification of diagnostic subnetwork markers for cancer in human protein-protein interaction network , 2010, BMC Bioinformatics.
[9] Roded Sharan,et al. Efficient Algorithms for Detecting Signaling Pathways in Protein Interaction Networks , 2006, J. Comput. Biol..
[10] Barbara McGrogan,et al. Taxanes, microtubules and chemoresistant breast cancer. , 2008, Biochimica et biophysica acta.
[11] Leming Shi,et al. Effect of training-sample size and classification difficulty on the accuracy of genomic predictors , 2010, Breast Cancer Research.
[12] Pierre Baldi,et al. Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..
[13] Tobias Müller,et al. Identifying functional modules in protein–protein interaction networks: an integrated exact approach , 2008, ISMB.
[14] Igor Jurisica,et al. Inferring the functions of longevity genes with modular subnetwork biomarkers of Caenorhabditis elegans aging , 2010, Genome Biology.
[15] Martin Ester,et al. Inferring cancer subnetwork markers using density-constrained biclustering , 2010, Bioinform..
[16] B. Matthews. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.
[17] J. Ross,et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] L. Mirny,et al. Protein complexes and functional modules in molecular networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[20] L. Gianni,et al. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.
[21] Yi Huang,et al. Estrogen Receptor α Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death , 2007 .
[22] K. Hess,et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Johnston,et al. 5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.
[24] K. Coombes,et al. Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines , 2010, Breast Cancer Research and Treatment.
[25] Salim A. Chowdhury,et al. IDENTIFICATION OF COORDINATELY DYSREGULATED SUBNETWORKS IN COMPLEX PHENOTYPES by SALIM , 2010 .
[26] R. Hardman,et al. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. , 1997, Cancer research.
[27] David Cameron,et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer , 2009, Nature Medicine.
[28] Noga Alon,et al. Biomolecular network motif counting and discovery by color coding , 2008, ISMB.
[29] David Cameron,et al. Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic? , 2009, European journal of cancer.
[30] Serhiy Souchelnytskyi,et al. TGFβ1/Smad3 counteracts BRCA1-dependent repair of DNA damage , 2005, Oncogene.
[31] Yi Huang,et al. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. , 2007, Cancer research.
[32] Maria Kavallaris,et al. Microtubules and resistance to tubulin-binding agents , 2010, Nature Reviews Cancer.
[33] Rohit Bhargava,et al. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation , 2010, Modern Pathology.
[34] Kevin C. Dorff,et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models , 2010, Nature Biotechnology.
[35] Serhiy Souchelnytskyi,et al. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage. , 2005, Oncogene.
[36] T. Sørlie,et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.
[37] M. Kavallaris. Microtubules and resistance to tubulin-binding agents , 2010, Nature Reviews. Cancer.
[38] A Kondepudi,et al. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain. , 1996, Endocrinology.
[39] Salim A. Chowdhury,et al. Subnetwork State Functions Define Dysregulated Subnetworks in Cancer , 2010, RECOMB.
[40] Maqc Consortium. The MicroArray Quality Control ( MAQC )-II study of common practices for the development and validation of microarray-based predictive models , 2012 .
[41] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[42] Richard M. Karp,et al. Detecting Disease-Specific Dysregulated Pathways Via Analysis of Clinical Expression Profiles , 2008, RECOMB.
[43] R. Sainson,et al. A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane* , 2007, Journal of Biological Chemistry.
[44] Xing-Ming Zhao,et al. A systems biology approach to identify effective cocktail drugs , 2010, BMC Systems Biology.
[45] Martin Ester,et al. Quantifying Systemic Evolutionary Changes by Color Coding Confidence-Scored PPI Networks , 2009, WABI.
[46] D. Yee,et al. Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects , 1999, Breast Cancer Research and Treatment.
[47] Roded Sharan,et al. Topology-Free Querying of Protein Interaction Networks , 2009, RECOMB.
[48] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[49] Noga Alon,et al. Color-coding , 1995, JACM.
[50] F. Shibasaki,et al. Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2. , 2001, Journal of biochemistry.
[51] Roded Sharan,et al. QNet: A Tool for Querying Protein Interaction Networks , 2007, RECOMB.
[52] Jae K. Lee,et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery , 2007, Proceedings of the National Academy of Sciences.
[53] L. Ein-Dor,et al. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] X-S Zhang,et al. Identifying differentially expressed pathways via a mixed integer linear programming model. , 2009, IET systems biology.
[55] Roded Sharan,et al. QPath: a method for querying pathways in a protein-protein interaction network , 2006, BMC Bioinformatics.